Phân tích biến dị chiều dài đoạn cắt hạn chế HLA-DQ beta-chain như một dấu hiệu nguy cơ trong bệnh tiểu đường loại 1 (phụ thuộc insulin): một nghiên cứu gia đình tại Phần Lan

Owerbach D, Lernmark Å, Platz P, Ryder LP, Rask L, Peterson PA, Ludvigsson J (1983) HLA-D region beta-chain DNA endonuclease fragments differ between HLA-DR identical healthy and insulin-dependent diabetic individuals. Nature 303: 815–817 Cohen-Haguenauer O, Robbins E, Massart C, Busson M, Deschamps I, Hors J, Lalouel J-M, Dausset J, Cohen D (1985) A systematic study of HLA class II-beta DNA restriction fragments in insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 82: 3335–3339 Todd JA, Bell JI, McDevitt HO (1987) HLA-DQ beta-gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329: 599–604 Deschamps I, Marcelli-Barge A, Lallemand N, Poirier JC, Bochu V, Prevost P, Busson A, Masset M, Lestradet H, Hors J (1988) Study of cis and trans interactions between extended HLA-haplotypes in insulin-dependent diabetes. Tissue Antigens 31: 259–269 Ilonen J, Surcel H-M, Partanen J, Koskimies S, Knip M, Käär M-L (1988) Extended HLA haplotypes in patients with insulin-dependent diabetes mellitus in Northern Finland. Tissue Antigens 32: 139–144 Monos DS, Mickelson E, Hansen JA, Baker L, Zmijewski CM, Kamoun M (1988) Analysis of DR and DQ gene products of the DR4 haplotype in patients with IDDM: possible involvement of more than one locus. Hum Immunol 23: 289–299 Sheehy MJ, Scharf SJ, Rowe JR, de Gimenez MH, Meske LM, Erlich HA, Nepom BS (1989) A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles. J Clin Invest 83: 830–835 Michelsen B, Lernmark Å (1987) Molecular cloning of a polymorphic DNA endonuclease fragment associates insulin-dependent diabetes mellitus with HLA-DQ. J Clin Invest 79: 1144–1152 Southern EM (1975) Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 98: 503–517 Maniatis T, Fritsch EF, Sambrook J (eds) (1982) Molecular cloning. Cold Spring Harbor, New York Ausubell F, Brent R, Kingston R, Moore D, Smith J, Seidman JG, Struhl K (eds) (1987) Current protocols in molecular biology. Greene Publ Assoc, New York Mattiuz PL, Ihde D, Piazza A, Ceppellini R, Bodmer WF (1970) New approaches to the population genetic and segregation analysis of the HLA system. In: Terasaki PI (ed) Histocompatibility testing. Munksgaard, Copenhagen, pp 193–205 Böhme J, Carlson B, Wallin J, Möller E, Persson B, Peterson PA, Rask L (1986) Only one DQ beta restriction fragment pattern of each DR specificity is associated with insulin-dependent diabetes. J Immunol 137: 941–947 Nepom BS, Palmer J, Kim SJ, Hansen JA, Holbeck SL, Nepom GT (1986) Specific genomic markers for the HLA-DQ subregion discriminate between DR4 + insulin-dependent diabetes mellitus and DR4 + seropositive juvenile rheumatoid arthritis. J Exp Med 164: 345–350 Henson V, Maclaren N, Riley W, Wakeland EK (1987) Polymorphism of DQ beta genes in HLA-DR4 haplotypes from healthy and diabetic individuals. Immunogenetics 25: 152–160 Carrier CM, Mollen N, Rothman WC, de Cordoba SR, Rey-Campos J, Ginsberg-Fellner F, Carpenter C, Rubinstein P (1989) Definition of IDDM-associated HLA DQ and DX RFLPs by segregation analysis of multiplex sibships. Hum Immunol 24: 51–63 Svejgaard A, Jakobsen BK, Platz P, Ryder LP, Nerup J, Cristy M, Borch-Johnsen K, Parving H-H, Deckert T, Molstedt-Pedersen L, Kuhl C, Buschard K, Green A (1986) HLA associations in insulin-dependent diabetes: search for heterogeneity in different groups of patients from a homogeneous population. Tissue Antigens 28: 237–244 Rönningen KJ, Markussen G, Iwe T, Thorsby E (1989) An increased risk of insulin-dependent diabetes mellitus (IDDM) among HLA-DR4, DQw8/DRw8, DQw4 heterozygotes. Hum Immunol 24: 165–173 Vela M, Adorno D, Longo A, Papola F, Maccarone D, Centis D, Raponi MP, Candela A, Campea L, Orsini M, Ferrara GB (1987) HLA typing data on 100 type I (insulin-dependent) diabetic patients from central Italy show a negative association with DR5 rather than with DR2. Clin Immunol Immunopathol 45: 143–146 Thivolet C, Beaufrere B, Betuel H, Gebuhrer L, Chatelain P, Durand A, Tourniaire J, Francois R (1988) Islet cell and insulin autoantibodies in subjects at high risk for development of Type 1 (insulin-dependent) diabetes mellitus: the Lyon family study. Diabetologia 31: 741–746 Trucco M, Ball E (1989) RFLP analysis of DQ-beta chain gene workshop report In: Dupont B (ed) Immunobiology of HLA, Vol 1. Springer, New York, pp 860–867 Bushell A, Wood KJ, Morris PJ (1988) DQ Wa gives rise to a DQ beta restriction fragment pattern indistinguishable from that of the DQw3.2 sub-type of DQw3. Tissue Antigens 32: 41–45 Aparicio JMR, Wakisaka A, Takada A, Ma'tsuura N, Aizawa M (1988) HLA-DQ system and insulin-dependent diabetes mellitus in Japanese: does it contribute to the development of IDDM as it does in Caucasians? Immunogenetics 28: 240–246 Bertrams J, Baur MP (1984) Disease reports, insulin-dependent diabetes mellitus. In: Albert ED, Baur MP, Mayr WR (eds) Histocompatibility testing 1984. Report on the Ninth International Histocompatibility Workshop and Conference. Springer, Berlin Heidelberg New York, pp 348–358 Kida K, Mimura G, Kobayashi T, Nakamura K, Sonoda S, Inouye H, Tsuji K (1989) Immunogenetic heterogeneity in Type 1 (insulin-dependent) diabetes among Japanese — HLA antigens and organ-specific autoantibodies. Diabetologia 32: 34–39 Gregersen PK, Shen M, Song Q, Merryman P, Degar S, Seki T, Maccari J, Goldberg D, Murphy H, Schwenzer J, Wang CY, Winchester RJ, Nepom GT, Silver J (1986) Molecular diversity of HLA-DR4 haplotypes. Proc Natl Acad Sci USA 83: 2642–2646 Horn GT, Bugawan TL, Long CM, Manos MM, Ehrlich HA (1988) Sequence analysis of HLA class II genes from insulin-dependent diabetic individuals. Hum Immunol 21: 249–263 Schreuder GM, Tilanus MGJ, Bontrop RE, Bruining GJ, Giphart MJ, van Rood JJ, de Vries RRP (1986) HLA-DQ polymorphism associated with resistance to type I diabetes detected with monoclonal antibodies, isoelectric point differences, and restriction fragment length polymorphism. J Exp Med 164: 938–943 Sansom DM, Bidwell JL, Maddison PJ, Campion G, Klouda PT, Bradley BA (1987) HLA DQ alpha and DQ beta restriction fragment length polymorphism associated with Felty's Syndrome and DR4-positive rheumatoid arthritis. Hum Immunol 19: 269–278 Wallin J, Carlsson B, Ström H, Möller E (1988) A DR4-associated DR-DQ haplotype is significantly associated with rheumatoid arthritis. Arthritis Rheum 31: 72–79 Bignon JD, Ferec C, Barrier J, Pennec Y, Verlingue C, Cheneau ML, Lucas V, Muller JY, Saleun JP (1988) HLA class II genes polymorphism in DR4 giant cell arteritis patients. Tissue Antigens 32: 254–258 Åkerblom HK, Reunanen A (1985) The epidemiology of insulin-dependent diabetes mellitus (IDDM) in Finland and in Northern Finland. Diabetes Care 8 [Suppl 1]: 10–16 Morel PA, Dorman JS, Todd JA, McDevitt HO, Trucco M (1988) Aspartic acid at position 57 of the HLA-DQ beta chain protects against type I diabetes: a family study. Proc Natl Acad Sci USA 85: 8111–8115